Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding Pharvaris N.V. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 22 | 20 | −2 |
| Shares | 21.7M | 22.4M | +668.0K (+3.1%) |
| Value | $397.1M | $494.0M | +$96.9M (+24.4%) |
New holders (1)
Institutions that held Pharvaris N.V. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| 5AM Venture Management, LLC | 587,600 | $13.0M | 3.21% |
Sold out (3)
Institutions that held Pharvaris N.V. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| DAFNA Capital Management LLC | 34,615 | $628.0K |
| JPMorgan Chase & Co | 3,429 | $64.0K |
| Tower Research Capital LLC (TRC) | 77 | $1.00K |